These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 38828112)
1. Malaria β-Haematin in blood results in synergistic attenuation enhancement: Studies with a conventional multimode reader and a custom LED device. Chan EY; Maiorca K; Bae C; Sharpe N; Tripuraneni V; Sharpe JZ Malariaworld J; 2013; 4():7. PubMed ID: 38828112 [No Abstract] [Full Text] [Related]
2. Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment). Egan TJ; Ross DC; Adams PA FEBS Lett; 1994 Sep; 352(1):54-7. PubMed ID: 7925942 [TBL] [Abstract][Full Text] [Related]
3. Monocyte phagocytosis of malaria β-haematin in the presence of artemisinin, amodiaquine, chloroquine, doxycycline, primaquine, pyrimethamine and quinine. Cumming BM; Goldring JPD Exp Parasitol; 2019 Feb; 197():93-102. PubMed ID: 30562480 [TBL] [Abstract][Full Text] [Related]
4. Destabilisation and subsequent lysis of human erythrocytes induced by Plasmodium falciparum haem products. Omodeo-Salè F; Motti A; Dondorp A; White NJ; Taramelli D Eur J Haematol; 2005 Apr; 74(4):324-32. PubMed ID: 15777345 [TBL] [Abstract][Full Text] [Related]
5. Bayesian models trained with HTS data for predicting β-haematin inhibition and in vitro antimalarial activity. Wicht KJ; Combrinck JM; Smith PJ; Egan TJ Bioorg Med Chem; 2015 Aug; 23(16):5210-7. PubMed ID: 25573118 [TBL] [Abstract][Full Text] [Related]
6. Neutral lipids associated with haemozoin mediate efficient and rapid β-haematin formation at physiological pH, temperature and ionic composition. Ambele MA; Egan TJ Malar J; 2012 Oct; 11():337. PubMed ID: 23043460 [TBL] [Abstract][Full Text] [Related]
7. Can hemozoin alone cause host anaemia? Sun J; Wang SW; Jin CL; Zeng XL; Piao XY; Bai L; Tang DL; Ji CL Parasitol Res; 2016 Dec; 115(12):4611-4616. PubMed ID: 27627911 [TBL] [Abstract][Full Text] [Related]
8. Kinetics of beta-haematin formation from suspensions of haematin in aqueous benzoic acid. Egan TJ; Tshivhase MG Dalton Trans; 2006 Nov; (42):5024-32. PubMed ID: 17060988 [TBL] [Abstract][Full Text] [Related]
9. Virtual screening as a tool to discover new β-haematin inhibitors with activity against malaria parasites. de Sousa ACC; Combrinck JM; Maepa K; Egan TJ Sci Rep; 2020 Feb; 10(1):3374. PubMed ID: 32099045 [TBL] [Abstract][Full Text] [Related]
10. The structure of malaria pigment beta-haematin. Pagola S; Stephens PW; Bohle DS; Kosar AD; Madsen SK Nature; 2000 Mar; 404(6775):307-10. PubMed ID: 10749217 [TBL] [Abstract][Full Text] [Related]
11. Crystallization of synthetic haemozoin (beta-haematin) nucleated at the surface of lipid particles. Hoang AN; Ncokazi KK; de Villiers KA; Wright DW; Egan TJ Dalton Trans; 2010 Feb; 39(5):1235-44. PubMed ID: 20104349 [TBL] [Abstract][Full Text] [Related]
12. On the preparation of beta-haematin. Blauer G; Akkawi M Biochem J; 2000 Mar; 346 Pt 2(Pt 2):249-50. PubMed ID: 10677340 [TBL] [Abstract][Full Text] [Related]
13. The chemical mechanism of beta-haematin formation studied by Mössbauer spectroscopy. Adams PA; Egan TJ; Ross DC; Silver J; Marsh PJ Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):25-7. PubMed ID: 8761447 [TBL] [Abstract][Full Text] [Related]
14. Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases. Warhurst DC; Craig JC; Adagu IS; Guy RK; Madrid PB; Fivelman QL Biochem Pharmacol; 2007 Jun; 73(12):1910-26. PubMed ID: 17466277 [TBL] [Abstract][Full Text] [Related]
15. Formation of haemozoin/beta-haematin under physiological conditions is not spontaneous. Pandey AV; Tekwani BL FEBS Lett; 1996 Sep; 393(2-3):189-93. PubMed ID: 8814287 [TBL] [Abstract][Full Text] [Related]
16. Comparison of visual and automated Deki Reader interpretation of malaria rapid diagnostic tests in rural Tanzanian military health facilities. Kalinga AK; Mwanziva C; Chiduo S; Mswanya C; Ishengoma DI; Francis F; Temu L; Mahikwano L; Mgata S; Amoo G; Anova L; Wurrapa E; Zwingerman N; Ferro S; Bhat G; Fine I; Vesely B; Waters N; Kreishman-Deitrick M; Hickman M; Paris R; Kamau E; Ohrt C; Kavishe RA Malar J; 2018 May; 17(1):214. PubMed ID: 29843721 [TBL] [Abstract][Full Text] [Related]
17. A comparison and analysis of several ways to promote haematin (haem) polymerisation and an assessment of its initiation in vitro. Dorn A; Vippagunta SR; Matile H; Bubendorf A; Vennerstrom JL; Ridley RG Biochem Pharmacol; 1998 Mar; 55(6):737-47. PubMed ID: 9586945 [TBL] [Abstract][Full Text] [Related]
18. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Dorn A; Vippagunta SR; Matile H; Jaquet C; Vennerstrom JL; Ridley RG Biochem Pharmacol; 1998 Mar; 55(6):727-36. PubMed ID: 9586944 [TBL] [Abstract][Full Text] [Related]